https://www.globenewswire.com/news-release/2025/07/08/3111596/0/en/ProKidney-Reports-Statistically-and-Clinically-Significant-Topline-Results-for-the-Phase-2-REGEN-007-Trial-Evaluating-Rilparencel-in-Patients-with-Chronic-Kidney-Disease-and-Diabet.html